507 related articles for article (PubMed ID: 31023032)
1. Proteogenomic Platform for Identification of Tumor Specific Antigens.
Faktor J; Hernychová L; Vojtěšek B; Hupp T
Klin Onkol; 2018; 31(Suppl 2):102-107. PubMed ID: 31023032
[TBL] [Abstract][Full Text] [Related]
2. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
[TBL] [Abstract][Full Text] [Related]
3. ProGeo-neo: a customized proteogenomic workflow for neoantigen prediction and selection.
Li Y; Wang G; Tan X; Ouyang J; Zhang M; Song X; Liu Q; Leng Q; Chen L; Xie L
BMC Med Genomics; 2020 Apr; 13(Suppl 5):52. PubMed ID: 32241270
[TBL] [Abstract][Full Text] [Related]
4. [Building Mass Spectrometry Spectral Libraries of Human Cancer Cell Lines].
Faktor J; Bouchal P
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):54-58. PubMed ID: 27846721
[TBL] [Abstract][Full Text] [Related]
5. A proteogenomic approach to target neoantigens in solid tumors.
Verma A; Halder A; Marathe S; Purwar R; Srivastava S
Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
[TBL] [Abstract][Full Text] [Related]
6. Importance of Membrane Proteins in the Treatment of Tumor Diseases and the Possibilities of Their Further Study.
Dosedělová L; Nekulová M; Zahradníková M; Faktor J; Vojtěšek B; Hernychová L
Klin Onkol; 2018; 31(Suppl 2):32-40. PubMed ID: 31023022
[TBL] [Abstract][Full Text] [Related]
7. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice.
Barajas A; Amengual-Rigo P; Pons-Grífols A; Ortiz R; Gracia Carmona O; Urrea V; de la Iglesia N; Blanco-Heredia J; Anjos-Souza C; Varela I; Trinité B; Tarrés-Freixas F; Rovirosa C; Lepore R; Vázquez M; de Mattos-Arruda L; Valencia A; Clotet B; Aguilar-Gurrieri C; Guallar V; Carrillo J; Blanco J
J Transl Med; 2024 Jan; 22(1):14. PubMed ID: 38172991
[TBL] [Abstract][Full Text] [Related]
8. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
Aldous AR; Dong JZ
Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
[TBL] [Abstract][Full Text] [Related]
9. Personalized neoantigen vaccination with synthetic long peptides: recent advances and future perspectives.
Chen X; Yang J; Wang L; Liu B
Theranostics; 2020; 10(13):6011-6023. PubMed ID: 32483434
[TBL] [Abstract][Full Text] [Related]
10. Effect of DNA Methylation on the Development of Cancer.
Holčáková J
Klin Onkol; 2018; 31(Suppl 2):41-45. PubMed ID: 31023023
[TBL] [Abstract][Full Text] [Related]
11. Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.
Li L; Zhang X; Wang X; Kim SW; Herndon JM; Becker-Hapak MK; Carreno BM; Myers NB; Sturmoski MA; McLellan MD; Miller CA; Johanns TM; Tan BR; Dunn GP; Fleming TP; Hansen TH; Goedegebuure SP; Gillanders WE
Genome Med; 2021 Apr; 13(1):56. PubMed ID: 33879241
[TBL] [Abstract][Full Text] [Related]
12. Advances in personalized neoantigen vaccines for cancer immunotherapy.
Sun C; Xu S
Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
[TBL] [Abstract][Full Text] [Related]
13. HDM2 and HDMX Proteins in Human Cancer.
Hároníková L; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):63-70. PubMed ID: 31023026
[TBL] [Abstract][Full Text] [Related]
14. Neoantigen prediction and computational perspectives towards clinical benefit: recommendations from the ESMO Precision Medicine Working Group.
De Mattos-Arruda L; Vazquez M; Finotello F; Lepore R; Porta E; Hundal J; Amengual-Rigo P; Ng CKY; Valencia A; Carrillo J; Chan TA; Guallar V; McGranahan N; Blanco J; Griffith M
Ann Oncol; 2020 Aug; 31(8):978-990. PubMed ID: 32610166
[TBL] [Abstract][Full Text] [Related]
15. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.
Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633
[TBL] [Abstract][Full Text] [Related]
16. Current Methods of microRNA Analysis.
Bartošík M; Jiráková L
Klin Onkol; 2018; 31(Suppl 2):93-101. PubMed ID: 31023031
[TBL] [Abstract][Full Text] [Related]
17. The Role of HSF1 Protein in Malignant Transformation.
Šimončík O; Pastorek M; Vojtěšek B; Müller P
Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025
[TBL] [Abstract][Full Text] [Related]
18. Acetylsalicylic Acid and its Potential for Chemoprevention of Colorectal Carcinoma.
Podhorec J; Hrstka R; Bílek O; Tuček Š; Navrátil J; Michalová E; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):77-81. PubMed ID: 31023028
[TBL] [Abstract][Full Text] [Related]
19. Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.
Skoupilová H; Michalová E; Hrstka R
Klin Onkol; 2018; 31(Suppl 2):21-26. PubMed ID: 31023020
[TBL] [Abstract][Full Text] [Related]
20. Application of mass spectrometry-based MHC immunopeptidome profiling in neoantigen identification for tumor immunotherapy.
Zhang X; Qi Y; Zhang Q; Liu W
Biomed Pharmacother; 2019 Dec; 120():109542. PubMed ID: 31629254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
